Candriam Equities L Biotech.R EUR Acc/ LU1269736838 /
| NAV2024-04-18 | Chg.-3.4000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 306.6200EUR | -1.10% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.24 | 8.73 | -8.18 | 11.89 | -1.92 | 3.11 | -10.47 | 12.83 | -2.22 | - |
| 2017 | 3.03 | 8.72 | -0.49 | -0.67 | -5.96 | 7.91 | -0.89 | 5.99 | 1.53 | -5.17 | -2.11 | 0.80 | +12.13% |
| 2018 | 2.91 | -2.52 | -2.89 | -1.42 | 8.33 | 0.84 | 4.25 | 4.77 | -1.87 | -11.81 | 4.26 | -9.14 | -6.05% |
| 2019 | 12.77 | 4.42 | 0.90 | -4.71 | -3.87 | 7.14 | 0.09 | -1.23 | -3.48 | 8.72 | 13.36 | 1.02 | +38.52% |
| 2020 | -4.00 | -0.60 | -4.83 | 12.62 | 7.87 | 0.37 | -7.82 | -0.23 | 2.77 | -1.95 | 6.65 | 0.73 | +10.25% |
| 2021 | 2.59 | -2.45 | -1.09 | 0.34 | -3.37 | 9.30 | -1.40 | 4.43 | -2.41 | 0.36 | -1.64 | 1.42 | +5.54% |
| 2022 | -9.24 | -1.70 | 7.12 | -2.10 | -5.38 | 6.12 | 7.42 | 3.02 | 0.75 | 5.62 | 1.98 | -6.23 | +5.80% |
| 2023 | 1.20 | -3.34 | -2.09 | 0.70 | 2.65 | -0.83 | -1.56 | 1.42 | -2.03 | -5.90 | 2.91 | 12.30 | +4.44% |
| 2024 | 3.27 | 1.79 | 0.23 | -6.67 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.38% | 18.76% | 16.02% | 20.23% | 23.18% |
| Sharpe ratio | -0.58 | 0.67 | 0.06 | 0.08 | 0.24 |
| Best month | +12.30% | +12.30% | +12.30% | +12.30% | +13.36% |
| Worst month | -6.67% | -6.67% | -6.67% | -9.24% | -9.24% |
| Maximum loss | -9.21% | -9.21% | -13.73% | -19.49% | -27.31% |
| Outperformance | -2.53% | - | -0.31% | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,907.8900 | +1.19% | +2.22% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 207.9900 | +3.96% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,913.8500 | -1.08% | -4.90% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,088.4600 | +4.19% | +16.22% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,216.7700 | +0.94% | +13.30% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 338.7400 | +1.84% | +17.28% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 306.6200 | +4.92% | +17.71% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 187.5400 | -2.57% | -5.90% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,712.9500 | +2.65% | +6.11% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 139.2100 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 557.7100 | +0.72% | +0.54% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,220.0698 | +1.07% | +1.84% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 183.8400 | -0.65% | -4.07% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 191.5600 | +0.20% | -1.72% | |
| Candriam Equities L Biotech.R US... | reinvestment | 248.3400 | +2.39% | +5.32% | |
| Candriam Equities L Biotech.C US... | reinvestment | 782.5900 | +1.09% | +1.82% | |
| Candriam Equities L Biotech.C US... | paying dividend | 718.9100 | +1.06% | +1.72% |
Performance
| YTD | -1.67% | ||
|---|---|---|---|
| 6 Months | +7.91% | ||
| 1 Year | +4.92% | ||
| 3 Years | +17.71% | ||
| 5 Years | +57.67% | ||
| Since start | +104.41% | ||
| Year | |||
| 2023 | +4.44% | ||
| 2022 | +5.80% | ||
| 2021 | +5.54% | ||
| 2020 | +10.25% | ||
| 2019 | +38.52% | ||
| 2018 | -6.05% | ||
| 2017 | +12.13% | ||
